Role of plasma adenosine in the antiplatelet action of hl 725, a potent inhibitor of camp phosphodiesterase: Species differences.-Reference-Cited by-同舟云学术

Role of plasma adenosine in the antiplatelet action of hl 725, a potent inhibitor of camp phosphodiesterase: Species differences.

Published:1987-07 Issue:2 Volume:47 Page:191-200
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Agarwal Kailash C.,Buckley Ralph S.,Parks Robert E.

Publisher

Elsevier BV

Subject

Hematology

Reference29 articles.

1. HL 725, an extremely potent inhibitor of platelet phosphodiesterase and induced platelet aggregation in vitro;Ruppert;Life Sci.,1982

2. Cardiovascular and antihypertensive activity of the new vasodilator 9,10-dimethoxy-2-mesitylimino-3-methyl-3,4,6,7-tetrahydro-2H-pyrimido(6,1-A)-isoquinoline-4-one-hydrochloride (HL 725);LAL;IRCS Bioch.,1981

3. In vivo interaction of prostacyclin with an inhibitor of cyclic phosphodiesterase, HL 725;Dorius;Br. J. Pharmacol.,1985

4. Prostacyclin is a circulating hormone;Moncada;Nature,1978

5. Modulation of human platelet adenylate cyclase by prostacyclin (PGX);Gorman;Prostaglandins,1977

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synergistic effect of cilostazol and dipyridamole mediated by adenosine on shear-induced platelet aggregation;Thrombosis Research;2007-01

2. Cilostazol and Dipyridamole Synergistically Inhibit Human Platelet Aggregation;Journal of Cardiovascular Pharmacology;2004-08

3. Cilostazol as a Unique Antithrombotic Agent;Current Pharmaceutical Design;2003-11-01

4. New Mechanism of Action for Cilostazol: Interplay Between Adenosine and Cilostazol in Inhibiting Platelet Activation;Journal of Cardiovascular Pharmacology;2002-10

5. Plasma adenosine levels increase in women with normal pregnancies;American Journal of Obstetrics and Gynecology;2000-05